On December 31, 1993, Microsoft (MSFT) had a market capitalization of $15B, based on 9.63B shares at a price of $1.55.

On December 30, 1994, Gap (GAP) had a market capitalization of $2.6B, based on 1.04B shares at a price of $2.53.

On October 1, 1996, ProPhase Labs (PRPH) had a market capitalization of $12.1M, based on 13.61M shares at a price of $0.89.

On December 31, 1993, Gap (GAP) had a market capitalization of $21.7B, based on 986.25M shares at a price of $22.04.

On December 31, 1992, Gap (GAP) had a market capitalization of $2.4B, based on 885.71M shares at a price of $2.71.

Sorry, available market cap data for ProPhase Labs (PRPH) starts on October 1, 1996. ProPhase Labs (PRPH) has a market capitalization of $46.6M, based on 19.08M shares at a price of $2.44 (up 2.5% yesterday).

Lisata Therapeutics (LSTA) had the highest return between 1994 and 1997 by a US stock, returning 1,178,471.4%.

Portage Biotech (PRTG) had the highest return between 1995 and 1997 by a US stock, returning 111,900%.

Madrigal Pharmaceuticals (MDGL) had the highest return between November 1, 2022 and December 31, 2022 by a mid-cap US stock or mid-cap US stock, returning 301.6%.

INVO Bioscience (INVO) returned -85% last year.

INVO Bioscience (INVO) returned -58.4% in 2019.

INVO Bioscience (INVO) returned 169.2% in 2018.

INVO Bioscience (INVO) returned -55.7% in 2017.

INVO Bioscience (INVO) returned 914.5% in 2016.

INVO Bioscience (INVO) returned -86.5% in 2015.